Skip to main content
Premium Trial:

Request an Annual Quote

Valigen to Apply Third Wave Agbio Technology to Genetically Modified Plants

NEW YORK, July 18 – Third Wave Agbio said Wednesday that Valigen has agreed to use its Invader SNP analysis platform to study genetic variations in plants.

As part of its research into developing agricultural products with improved traits, Valigen, headquartered in Paris-la-Defense, France, will use Third Wave Agbio’s technology to detect genetic changes in plants modified using Valigen’s Genoplasty technology. 

Financial details of the deal were not disclosed. 

The Genoplasty technology allows Valigen to introduce an oligonucleotide into a target cell, and use the cell’s mechanism for DNA repair to modify its genetic sequence according to the sequence of the oligonucleotide.

Third Wave Technologies, based in Madison, Wisc., is a significant stakeholder in Third Wave Agbio, also of Madison.  

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.